Kassi Filkins, Editor

Arjan Hura, MD, gives a sneak peek of the 17th annual Controversies in Modern Eye Care meeting being held this April in Los Angeles.

Following the submission of the 24-month phase 3 data in November 2022, Apellis received FDA approval for intravitreal pegcetacoplan (SYFOVRE) to treat geographic atrophy secondary to AMD.

Jason Romero, a legally blind ultra-runner, will be giving the keynote address at the 2023 Vision Expo East meeting March 16-19 in New York City.

A look back on what's happened in optometry during the week of February 11-February 16.

Loretta Szczotka-Flynn, OD, PhD, sits down to discuss the International Keratoconus Academy's first annual keratoconus symposium, which will be held April 22-23, 2023, in Scottsdale, Arizona.

In this episode of a practice management series with Maria Sampalis, OD, learn about different online promotions and how to put them into practice.

Vote in our most recent poll!

See the results from our recent poll!

A look back on what's happened in optometry during the week of February 4-February 9.

Aflibercept, a VEGF inhibitor previously indicated for a variety of retinal diseases, is the first pharmacological treatment for retinopathy of prematurity in preterm infants.

Hear from Robert Maloney, MD, about what to expect—and what he's excited about—for this year's 2023 Controversies in Modern Eye Care meeting held this April in Los Angeles, California.

In this episode of a practice management series with Maria Sampalis, OD, hear how to reach your target audience.

Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.

Danica Marrelli, OD, FAAO, shares key highlights from her presentation, which she presented during the Glaucoma 360 meeting held this year in San Francisco.

A look back on what's happened in optometry during the week of Jan. 28-Feb. 2.

In this episode of a practice management series with Maria Sampalis, OD, learn about the importance of social media use as a local optometrist.

Bausch + Lomb and Modulight announce the photodynamic laser for use with photodynamic therapy was approved by the FDA for the treatment of patients with subfoveal choroidal neovascularization due to AMD.

A wave of infections across 11 states have been linked to artificial tear use, leading to permanent vision loss, hospitalization, and one death.

A look back on what's happened in optometry during the week of Jan. 21-Jan. 26.

In this first episode of a practice management series with Maria Sampalis, OD, learn about the importance of a brand for your optometric practice.

Essence Johnson, OD, FAAO, Dipl ABO, has been appointed as the first Black EyeCare Perspective executive director.

A look back on what's happened in optometry during the week of Jan. 14-Jan. 19.

IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying emergency department patients with sepsis and contribute to rapid life-saving decisions.

Company magnifies impact of sustainability program as it celebrates milestone: 100 million plastic bottles prevented from reaching Earth’s oceans

A look back on what's happened in optometry during the week of Jan. 7-Jan. 12, 2023.

A look back on what's happened in optometry during the week of Jan. 1-Jan. 5, 2023.

The 'Screen, Protect, Cure' campaign aims to education individuals who may be at risk for glaucoma, while raising funding for glaucoma research during Glaucoma Awareness Month.

Leo Semes, OD, FAAO, shares key highlights from his EyeCon 2022 presentation, "Advances in therapies for retinal disease."

As 2022 comes to a close, check out some of the hottest and most-liked stories from the year!

Marc R. Bloomenstein, OD, FAAO, gives an overview of the SAHARA study.